- Home
- AIOT vs PLRX Comparison
AIOT vs PLRX Comparison
Compare AIOT & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIOT
- PLRX
- Stock Information
- Founded
- AIOT 1993
- PLRX 2015
- Country
- AIOT United States
- PLRX United States
- Employees
- AIOT N/A
- PLRX N/A
- Industry
- AIOT Telecommunications Equipment
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- AIOT Telecommunications
- PLRX Health Care
- Exchange
- AIOT Nasdaq
- PLRX Nasdaq
- Market Cap
- AIOT 687.0M
- PLRX 641.5M
- IPO Year
- AIOT N/A
- PLRX 2020
- Fundamental
- Price
- AIOT $7.11
- PLRX $12.98
- Analyst Decision
- AIOT Buy
- PLRX Strong Buy
- Analyst Count
- AIOT 2
- PLRX 7
- Target Price
- AIOT $12.50
- PLRX $40.50
- AVG Volume (30 Days)
- AIOT 1.7M
- PLRX 500.0K
- Earning Date
- AIOT 11-12-2024
- PLRX 11-07-2024
- Dividend Yield
- AIOT N/A
- PLRX N/A
- EPS Growth
- AIOT N/A
- PLRX N/A
- EPS
- AIOT N/A
- PLRX N/A
- Revenue
- AIOT $221,073,000.00
- PLRX N/A
- Revenue This Year
- AIOT $153.13
- PLRX N/A
- Revenue Next Year
- AIOT $21.07
- PLRX $585.71
- P/E Ratio
- AIOT N/A
- PLRX N/A
- Revenue Growth
- AIOT 67.23
- PLRX N/A
- 52 Week Low
- AIOT $2.22
- PLRX $10.22
- 52 Week High
- AIOT $7.23
- PLRX $19.62
- Technical
- Relative Strength Index (RSI)
- AIOT 74.45
- PLRX 44.30
- Support Level
- AIOT $5.85
- PLRX $12.01
- Resistance Level
- AIOT $6.57
- PLRX $12.94
- Average True Range (ATR)
- AIOT 0.47
- PLRX 0.88
- MACD
- AIOT 0.15
- PLRX -0.23
- Stochastic Oscillator
- AIOT 95.06
- PLRX 28.11
About AIOT PowerFleet Inc. Common Stock
PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.